<DOC>
	<DOCNO>NCT02392130</DOCNO>
	<brief_summary>The purpose study assess effect LEO 130852A gel 1 % maintain skin thickness healthy skin treat steroid .</brief_summary>
	<brief_title>A Clinical Trial Assess Potential LEO 130852A Gel Reduce Steroid Induced Skin Atrophy Healthy Skin</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Healthy male volunteer , 25 50 year old inclusive Healthy skin volar arm hairless area sufficient measurement Clinical skin atrophy , telangiectasia stria volar arm Presence skin condition colouration would interfere test site response assessment Fitzpatrick skin type IV VI History current evidence infection , eczema relevant skin disease</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>